Teva Case Study | Biopharma | AWS
Teva reaches $523 million deal to settle opioid lawsuit with New York | CNN Business
Jury holds drugmaker Teva liable in opioid crisis | WCHS
Teva to Pay $85 Million Settlement in Oklahoma Opioid Case - Bloomberg
Teva Pharmaceuticals USA found liable in opioids case - Newsday
Opioid firm Teva agrees $85m settlement days before Oklahoma case goes to court | US News | Sky News
Teva agrees to $85 million settlement in opioid public nuisance case
Teva settles with Oklahoma for $85 million in opioid case | The Times of Israel
Teva-Settles-PayDelay-Case
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
Teva Settles Arkansas Price-Fixing Case for $931K | Arkansas Business News | ArkansasBusiness.com
Teva Agrees to Settle Opioid Lawsuits for as Much as $4.25 Billion - WSJ
Teva Gains 6.4% on Another Opioid Case Settlement - TipRanks.com
Teva Takes Second Swing at Redo of 'Skinny Label' Drug Case
Teva, denying 'any liability,' set aside $646M for opioid settlements. Here's why | Fierce Pharma
Sponsor's Content | Teva Pharmaceutical Reengineers Compliance With Data Analytics
Pharmaceutical Company Reaches Settlement With Oklahoma In Opioid Case : NPR
Teva Pharmaceuticals Found Liable For Opioid Crisis by Jury, Trial Will Determine Penalty
Drug Maker Teva to Pay Over $500 Million in New York Drug Case Settlement - The New York Times
Rhode Island takes Teva to trial in multibillion-dollar opioid case | Business Insurance
